INNOVATION PHARMACEUTICALS INC. Convertible Notes Payable
INNOVATION PHARMACEUTICALS INC. had Convertible Notes Payable of $238.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleNotesPayable · last filed 2023-11-20
- 2023-09-30: Convertible Notes Payable $238.00K.
- 2023-06-30: Convertible Notes Payable $213.00K.
- 2023-03-31: Convertible Notes Payable $238.00K.
- 2022-06-30: Convertible Notes Payable $250.00K.
| Period end | Convertible Notes Payable |
|---|---|
| 2023-09-30 | $238.00K 10-Q · filed 2023-11-20 |
| 2023-06-30 | $213.00K 10-Q · filed 2023-11-20 |
| 2023-03-31 | $238.00K 10-Q · filed 2023-05-15 |
| 2022-06-30 | $250.00K 10-Q · filed 2023-05-15 |